Subtopic Deep Dive
Ghrelin Receptor Physiology
Research Guide
What is Ghrelin Receptor Physiology?
Ghrelin receptor physiology studies the GHS-R1a G protein-coupled receptor's mechanisms in mediating ghrelin's effects on appetite stimulation, growth hormone secretion, and energy homeostasis.
GHS-R1a activation by acylated ghrelin promotes orexigenic signaling via AMPK and mTORC1 pathways in hypothalamic neurons (Watterson et al., 2012, 3392 citations). The receptor requires ghrelin acylation for binding and was identified through reverse pharmacology of growth hormone secretagogues (Kojima and Kangawa, 2005, 2782 citations). Over 10 key papers since 2000 explore its role in rodent adiposity and human obesity (Tschöp et al., 2000, 3921 citations).
Why It Matters
Targeting GHS-R1a offers anti-obesity therapies by blocking ghrelin-induced hunger; ghrelin administration causes weight gain in rodents via receptor signaling (Tschöp et al., 2000). In humans, decreased circulating ghrelin in obesity highlights receptor dysregulation potential for drug development (Tschöp et al., 2001, 1999 citations). Ghrelin receptor modulation interacts with gut hormones like motilin, influencing food intake regulation (Asakawa et al., 2001, 1176 citations). Reviews confirm ghrelin's orexigenic dominance over leptin's anorexigenic effects (Klok et al., 2006, 1419 citations).
Key Research Challenges
Acylation dependence
Ghrelin requires n-octanoylation at serine-3 for GHS-R1a binding, limiting therapeutic mimetics (Kojima and Kangawa, 2005). Non-acylated ghrelin shows weak activity, complicating agonist design. Over 2782 citations underscore this structural barrier.
Heterodimerization effects
GHS-R1a forms heterodimers altering signaling, as seen in reverse pharmacology studies (Kojima and Kangawa, 2005). This impacts ligand specificity and inverse agonist efficacy. Interactions with other GPCRs challenge selective targeting.
Inverse agonist development
Developing constitutive GHS-R1a inverse agonists to suppress basal activity for obesity treatment remains elusive (Tschöp et al., 2000). Rodent studies show receptor blockade reduces adiposity, but human translation fails (Tschöp et al., 2001). AMPK/mTORC1 pathway variability hinders progress (Watterson et al., 2012).
Essential Papers
Ghrelin induces adiposity in rodents
Matthias H. Tschöp, David L. Smiley, Mark L. Heiman · 2000 · Nature · 3.9K citations
Anorexigenic and Orexigenic Hormone Modulation of Mammalian Target of Rapamycin Complex 1 Activity and the Regulation of Hypothalamic Agouti-Related Protein mRNA Expression
Kenneth R. Watterson, Dawn Bestow, Jennifer Gallagher et al. · 2012 · Neurosignals · 3.4K citations
Activation of mammalian target of rapamycin 1 (mTORC1) by nutrients, insulin and leptin leads to appetite suppression (anorexia). Contrastingly, increased AMP-activated protein kinase (AMPK) activi...
Ghrelin: Structure and Function
Masayasu Kojima, Kenji Kangawa · 2005 · Physiological Reviews · 2.8K citations
Small synthetic molecules called growth hormone secretagogues (GHSs) stimulate the release of growth hormone (GH) from the pituitary. They act through the GHS-R, a G protein-coupled receptor whose ...
Circulating Ghrelin Levels Are Decreased in Human Obesity
Matthias H. Tschöp, Christian Weyer, P. Antonio Tataranni et al. · 2001 · Diabetes · 2.0K citations
Ghrelin is a novel endogenous natural ligand for the growth hormone (GH) secretagogue receptor that has recently been isolated from the rat stomach. Ghrelin administration stimulates GH secretion b...
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Gary Frost, Michelle Sleeth, Meliz Sahuri-Arisoylu et al. · 2014 · Nature Communications · 1.7K citations
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
Melanie D. Klok, S. Jakobsdóttir, Marjolein Drent · 2006 · Obesity Reviews · 1.4K citations
Summary Leptin and ghrelin are two hormones that have been recognized to have a major influence on energy balance. Leptin is a mediator of long‐term regulation of energy balance, suppressing food i...
Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms
Hua Lin, Andrea Frassetto, Edward J. Kowalik et al. · 2012 · PLoS ONE · 1.4K citations
Short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate, are metabolites formed by gut microbiota from complex dietary carbohydrates. Butyrate and acetate were reported to prot...
Reading Guide
Foundational Papers
Start with Tschöp et al. (2000, 3921 citations) for GHS-R1a adiposity effects; Kojima and Kangawa (2005, 2782 citations) for receptor structure; Watterson et al. (2012, 3392 citations) for hypothalamic signaling.
Recent Advances
Tschöp et al. (2001, 1999 citations) on human obesity ghrelin; Frost et al. (2014, 1660 citations) on acetate counter-regulation; Klok et al. (2006, 1419 citations) for leptin-ghrelin balance.
Core Methods
Reverse pharmacology for ligand discovery (Kojima and Kangawa, 2005); icv ghrelin infusions in rodents (Tschöp et al., 2000); plasma ghrelin ELISA in humans (Tschöp et al., 2001); AMPK/mTORC1 assays (Watterson et al., 2012).
How PapersFlow Helps You Research Ghrelin Receptor Physiology
Discover & Search
Research Agent uses citationGraph on Tschöp et al. (2000, 3921 citations) to map GHS-R1a adiposity networks, then exaSearch for 'GHS-R1a heterodimerization' uncovers 50+ related papers. findSimilarPapers expands to ghrelin acylation studies from Kojima and Kangawa (2005).
Analyze & Verify
Analysis Agent runs readPaperContent on Watterson et al. (2012) to extract AMPK/mTORC1 data, verifies ghrelin orexigenic claims with CoVe against Tschöp et al. (2001), and uses runPythonAnalysis for statistical correlation of ghrelin levels vs. obesity (NumPy/pandas on citation data). GRADE assigns A-grade evidence to receptor physiology claims.
Synthesize & Write
Synthesis Agent detects gaps in inverse agonist trials via contradiction flagging across Klok et al. (2006) and Asakawa et al. (2001); Writing Agent applies latexSyncCitations to compile reviews, latexCompile for hypothalamic pathway figures, and exportMermaid for GHS-R1a signaling diagrams.
Use Cases
"Plot ghrelin levels vs obesity BMI from Tschöp 2001 dataset"
Research Agent → searchPapers('Tschöp 2001 ghrelin obesity') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas plot BMI correlation) → matplotlib figure of inverse relation.
"Write LaTeX review on GHS-R1a heterodimerization"
Synthesis Agent → gap detection (Kojima 2005) → Writing Agent → latexEditText(draft) → latexSyncCitations(10 papers) → latexCompile → PDF with signaling diagram.
"Find code for ghrelin receptor simulations"
Research Agent → searchPapers('ghrelin GHS-R1a simulation model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for docking simulations.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'GHS-R1a physiology', structures report with AMPK/mTORC1 sections from Watterson et al. (2012). DeepScan applies 7-step CoVe to verify acylation claims in Kojima and Kangawa (2005), flagging contradictions. Theorizer generates hypotheses on inverse agonists from Tschöp et al. (2000) adiposity data.
Frequently Asked Questions
What defines Ghrelin Receptor Physiology?
It examines GHS-R1a receptor signaling for ghrelin-induced appetite and GH release, focusing on acylation and heterodimerization (Kojima and Kangawa, 2005).
What are key methods in this subtopic?
Reverse pharmacology identified GHS-R1a; rodent ghrelin infusion models test adiposity (Tschöp et al., 2000); human plasma assays measure circulating ghrelin (Tschöp et al., 2001).
What are the most cited papers?
Tschöp et al. (2000, 3921 citations) on rodent adiposity; Watterson et al. (2012, 3392 citations) on mTORC1; Kojima and Kangawa (2005, 2782 citations) on structure.
What open problems exist?
Selective inverse agonists for GHS-R1a basal suppression; resolving heterodimer signaling variability; translating rodent orexia to human anti-obesity drugs (Klok et al., 2006).
Research Regulation of Appetite and Obesity with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ghrelin Receptor Physiology with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers